STAT News

STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

Europe pulls Tavneos over trial integrity concerns, pricing concerns over AstraZeneca's hypertension drug, and more biotech news from The Readout

作者 STAT News

1 分钟阅读
STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit
STAT+: Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

相关洞察